BreachRx Closes $15M Series A to Revolutionize Cybersecurity Incident Response
Deal News | May 19, 2025 | Alchemist Accelerator LLC
BreachRx, a pioneer in intelligent incident response solutions, announced the closure of an oversubscribed $15 million Series A funding round. The round was led by Ballistic Ventures, with contributions from SYN Ventures, Overline, and Silver Buckshot Ventures. This investment increases the total funding raised by BreachRx to over $23 million. BreachRx's platform offers secure central workspaces enabling synchronized response management across enterprises—important in sectors like financial services, technology, and healthcare. With previous CEO of Mandiant, Kevin Mandia, joining the board, and cybersecurity expert Nicole Perlroth as a board observer, the firm is poised for growth. Their platform smartly addresses the intricate necessities of breaches, offering dynamic playbooks and audit reports, thus promoting visibility and precision in crisis situations. The funding will propel BreachRx's workforce expansion and platform evolution.
Sectors
- Cybersecurity
- Venture Capital
- Technology
Geography
- United States – The article references BreachRx, a company based in San Francisco. The location is integral, given the concentration of tech and venture capital activities.
Industry
- Cybersecurity – The article discusses BreachRx, a company specializing in cybersecurity solutions, and its impact on how organizations manage cyber incidents.
- Venture Capital – The article features a Series A funding round involving numerous VC firms such as Ballistic Ventures and SYN Ventures supporting BreachRx's growth.
- Technology – BreachRx provides a technology-driven platform that supports incident management for enterprises, implying active involvement in the technology sector.
Financials
- $15M – Series A funding round closed by BreachRx.
- $23M – Total funding raised by BreachRx to date.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| BreachRx | Target Company | Company | BreachRx provides an intelligent cybersecurity incident response platform for enterprises. |
| Ballistic Ventures | Lead Investor | Company | A venture capital firm leading BreachRx's Series A funding round. |
| SYN Ventures | Investor | Company | Participated as an investor in BreachRx's Series A funding round. |
| Overline | Investor | Company | Contributed to BreachRx's Series A funding round. |
| Silver Buckshot Ventures | Investor | Company | Another investor involved in BreachRx's Series A funding round. |
| Kevin Mandia | Board Member | Person | Former Mandiant CEO and now a member of BreachRx’s Board of Directors. |
| Nicole Perlroth | Board Observer | Person | An experienced author and former cybersecurity reporter, now a board observer at BreachRx. |
| Alchemist Accelerator LLC | PE Firm | Company | Reference as a PE Firm related to BreachRx. |